2012•Unpublished venueRequires access

Figure 150, Impact of injectable unfractionated heparin prophylaxis versus injectable or oral direct thrombin inhibitor prophylaxis on proximal deep vein thrombosis in patients undergoing major orthopedic surgery (same as limited to total hip replacement surgery)

Diana M Sobieraj, Craig Ian Coleman, Vanita Tongbram, Soyon Lee, Jennifer A. Colby, Wendy T Chen, Sagar S Makanji, Ajibade O. Ashaye, Jeffrey Kluger, C Michael White

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Orthopedic surgery, Surgery, Thrombosis, Deep vein, Rivaroxaban, Heparin, Venous thrombosis

Related papers

Back to paper searchBrowse research topicsOriginal source
Figure 150, Impact of injectable unfractionated heparin prophylaxis versus injectable or oral direct thrombin inhibitor prophylaxis on proximal deep vein thrombosis in patients undergoing major orthopedic surgery (same as limited to total hip replacement surgery) — Research Paper | ScholarLens